Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Scientists uncover factors influencing waning immunity with Pfizer COVID-19 vaccine

November 22, 2021 Sales and Marketing

Scientists have discovered multiple factors influencing declining immunity over time with the Pfizer COVID-19 vaccine, according to News Medical.
News

Emergex trial new form of COVID vaccine

November 15, 2021 Sales and Marketing

Emergex, an Oxfordshire based company, is moving towards Phase I trials for its novel COVID-19 vaccine, which is applied as …
News
11347696326_bac61dbf66_e

Theramex launches Femarelle to treat menopause symptoms

November 15, 2021 Sales and Marketing

Theramex recently announced that they have acquired the Femarelle ® product licence to treat menopause symptoms. The commercialisation agreement was reached …
News

Pfizer vaccine generates most antibodies, comparative study suggests

November 15, 2021 Sales and Marketing

Pfizer Inc. and BioNTech’s COVID-19 vaccine yielded the strongest immune response in a comparative study of four vaccines. The study, …
News

First patient dosed in tumour membrane immunotherapy trial

November 15, 2021 Sales and Marketing

Cytovation AS, a clinical stage immune-oncology company focused on the development of its first-in-class targeted tumour membrane immunotherapy, announced that …
News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Appointment

Diabetes drug dapagliflozin recommended by NICE for chronic kidney disease

November 8, 2021 Sales and Marketing

A study published in the journal Lancet states that a common diabetes drug may be an option for treating chronic …
News

HLB’s liver cancer treatment awarded Orphan Drug Status by FDA

November 8, 2021 Sales and Marketing

HLB have announced that its anticancer drug candidate, rivoceranib, has been awarded Orphan Drug Status by the FDA. HLB is …
News

UK government to roll out Merck antiviral pill, Pfizer COVID pill cuts hospitalisations by 89%

November 8, 2021 Sales and Marketing

The UK government will roll out Merck’s COVID-19 antiviral pill, molnupiravir, through drug trial later this month. In early November, …
News
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Appointment

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Feature
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Appointment

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …
Appointment

Skin patch COVID vaccine may prove more effective than injections

November 1, 2021 Sales and Marketing

A COVID vaccine skin patch is on course for its first human trial by the University of Queensland in partnership …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026